Skip to main content
SpringerLink
Log in

Hormone Dependent Breast Cancer

  • Chapter
Etiology of Cancer in Man

Part of the book series: Cancer Growth and Progression ((CAGP,volume 6))

  • 60 Accesses

Abstract

The role of steroid hormones in the development of adenocarcinoma of the breast is not well understood. As breast cancer rarely occurs in the undeveloped breast, it is at least clear that these hormones are necessary for the development of breast cancer insofar as they are necessary for mammary gland growth. The presence of estrogens and progesterone serves to prepare the background for the action of genetic factors, viruses and chemicals in the initiation of malignancy. Once initiated, many breast tumors remain under hormonal control. This chapter will review the current understanding of the role of steroid hormones in the epidemiology, biology and treatment of breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adami HO, Rimsten A, Stenkrist B: Reproductive history and breast cancer. Cancer 41:747, 1978

    PubMed  CAS  Google Scholar 

  2. Adams DJ, Edwards DP, McGuire WL: Estrogen regulations of specific messenger RNA’s in human breast cancer cells. Bioch Biophys Res Commun 97:1354, 1980

    CAS  Google Scholar 

  3. Adams JB, Li K: Biosynthesis of 17β-oestradiol in human breast carcinoma tissue and a novel method for its characterization. Br J Cancer 31:420, 1979

    Google Scholar 

  4. Allegra JC, Lippman ME: Estrogen receptor status and the disease free interval in breast cancer. Recent Results in Cancer Research 71:20, 1980

    PubMed  CAS  Google Scholar 

  5. Allegra JC, Lippman ME, Thompson EB, Simon R, Berlock A, Green L, Huff KK, Do HMT, Aitken SC, Warren R: Estrogen receptor status: an important variable in predicting response to endocrine therapy in metastatic breast cancer. Europ J Cancer 16:323, 1980

    CAS  Google Scholar 

  6. Anderson WA, Kang YH, Burnett C, Mohla S: Endogenous peroxidase: a biochemical marker of an estrogen-induced gene in normal and neoplastic tissues. J Cell Biol 83:242, 1979

    Google Scholar 

  7. Antoniades KE, Spector H: Correlation of estrogen receptor levels with histology and cytomorphology in human mammary cancer. Am J Clin Path 71:497, 1979

    PubMed  CAS  Google Scholar 

  8. Beatson GT: On the treatment of inoperable cases of carcinoma of the mamma: Suggestions for a new method of treatment, with illustrative cases. Lancet 2:104, 1896

    Google Scholar 

  9. Bertuzzi A, Daidone MF, DeFronzo G, Silverstini R: Relationship among estrogen receptor, proliferative activity, and menopausal status in breast cancer. Breast Cancer Res Treat 1.253, 1981

    PubMed  CAS  Google Scholar 

  10. Bishop HM, Elston CW, Blarney RW, Haybittle SL, Nicholson RI, Griffiths K: Relationship of oestrogen-receptor status to survival in breast cancer. Lancet 2:283, 1979

    PubMed  CAS  Google Scholar 

  11. Bloom HJG: Prognosis in carcinoma of the breast. Br J Cancer 4:259, 1950

    PubMed  CAS  Google Scholar 

  12. Bloom WD, Tobin EH, Schreibman B, Degenshein GA: The role of progesterone receptors in the management of advanced breast cancer. Cancer 45:2992, 1980

    PubMed  CAS  Google Scholar 

  13. Bronzert DA, Monaco ME, Pinkus L, Aitken S, Lippman ME: Purification and properties of estrogen responsive thymidine kinase from human breast cancer. Cancer Res 41:604, 1981

    PubMed  CAS  Google Scholar 

  14. Bullock LP, Bardin CW, Sherman MR: Androgenic, antian-drogenic and synandrogenic action of progestins: Role of steric and allosteric interactions with androgen receptors. Endocrinology 103:1768, 1978

    PubMed  CAS  Google Scholar 

  15. Butler WB, Kirkland WL, Jorgenson TL: Induction of plasminogen activator by estrogen in human breast cancer cell line CF-7). Biochem Biophys Res Commun 90:1328, 1979

    PubMed  CAS  Google Scholar 

  16. Campbell FC, Blarney RW, Elston CW, Nicholson RI, Griffiths K, Haybittle JL: Oestrogen-receptor status and sites of metastasis in breast cancer. Br J Cancer 44:456, 1981

    PubMed  CAS  Google Scholar 

  17. Chamness GC, Mercer WD, McGuire WL: Are histochemical methods for estrogen receptor valid? J Histochem Cyto-chem 28:792, 1980

    CAS  Google Scholar 

  18. Chamness GC, McGuire WL: Methods for analyzing steroid receptors in human breast cancer. In: Breast Cancer: Advances in Research and Treatment III, McGuire, W.L. (ed.), pp. 149–197, New York, Plenum Press, 1979

    Google Scholar 

  19. Champion HR, Wallace IW, Prescot RJ: Histology in breast cancer prognosis. Br J Cancer 26:129, 1972

    PubMed  CAS  Google Scholar 

  20. Clark GM, McGuire WL: Progesterone receptors and human breast cancer. Breast Cancer Res Treat 3:157, 1983

    CAS  Google Scholar 

  21. Cooke T, George WD, Griffiths K: Possible tests for selection of adjuvant systematic therapy in early carcinoma of the breast. Br J Surg 67:747, 1980

    PubMed  CAS  Google Scholar 

  22. Cowan LD, Gordis L, Tonaascia JA, Jones GS: Breast cancer incidence in women with a history of progesterone deficiency. Am J Epidemiol 114:209, 1981

    PubMed  Google Scholar 

  23. Delarue JC, May-Jevin F, Mouriesse H, Contesso G, Sancho-Gennier H: Oestrogen and progesterone cytolosic receptors in clinically inflammatory tumors of the human breast. Br J Cancer 44:911, 1981

    PubMed  CAS  Google Scholar 

  24. Drill VA: An overview of studies on estrogens, oral contraceptives and breast cancer. Progress Drug Research 25:159, 1981

    CAS  Google Scholar 

  25. Edwards DP, Adams DJ, Savage W, McGuire WL: Estrogen induced synthesis of specific proteins in human breast cancer cells. Biochem Biophys Res Commun 93:804, 1980

    PubMed  CAS  Google Scholar 

  26. Edwards DP, Chamness GC, McGuire WL: Estrogen and progesterone receptor proteins in breast cancer. Biochim Biophys Acta 560:457, 1979

    PubMed  CAS  Google Scholar 

  27. Edwards DP, McGuire WL: 17a Estradiol is a biologically active estrogen in breast cancer cells in tissue culture. Endocrinology 107:884, 1980

    PubMed  CAS  Google Scholar 

  28. Edwards DP, Murthy SR, McGuire WL: Effects of estrogen and antiestrogen on DNA polymerase in human breast cancer. Cancer Res 40:1722, 1980

    PubMed  CAS  Google Scholar 

  29. Fisher B, Redmond C, Brown A, Wickerman DL, Wolmack W, Allegra I, Escher G, Lippman M, Savlov E, Witliff J, Fisher ER, & other NSABP Investigators. Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer. J Clin Oncology 1(4):227, 1983

    CAS  Google Scholar 

  30. Fisher B, Wickerman DL, Brown A, Redmond CK, with contributions by other NSABP Investigators: Breast cancer estrogen and progesterone receptor values: their distribution, degree of concordance, and relation to number of positive axillary nodes. J Clin Oncology 1(6):349, 1983

    CAS  Google Scholar 

  31. Fisher ER: Pathology of breast cancer. In: Breast Cancer: Advances in Research and Treatment, McGuire WL (ed.), Vol. 1, pp. 43–123, New York, Plenum Press, 1977

    Google Scholar 

  32. Fisher ER, Osborne CK, McGuire WL, Redmond C, Knight WA III, Fisher B, Bannayan G, Walder A, Gregory EJ, Jacobsen A, Queen DM, Bennett DE, Ford HC: Correlation of primary breast cancer histopathology and estrogen receptor content. Breast Cancer Res Treat 1:37–41, 1980

    Google Scholar 

  33. Fisher ER, Redmond CK, Liu H, Rockette H, Fisher B, collaborating NSABP Investigators. Correlation of estrogen receptor and pathologic characteristic of invasive breast cancer. Cancer 45:349, 1980

    PubMed  CAS  Google Scholar 

  34. Folca PJ, Glascock RF, Irvin WT: Studies with tritium-labelled hexoestrol in advanced breast cancer. Lancet 2:796, 1961

    PubMed  CAS  Google Scholar 

  35. Furmanski P, Saunders DE, Brooks SC, Rich MA & the Breast Cancer Prognostic Study Clinical and Pathology Associates. The prognostic value of estrogen receptor determinations in patients with primary breast cancer. Cancer 46:2794, 1980

    PubMed  CAS  Google Scholar 

  36. Gapinski PV, Donegan WL: Estrogen receptors and breast cancer: prognostic and therapeutic implications. Surgery 88:386, 1980

    PubMed  CAS  Google Scholar 

  37. Gioanni J, Farges MF, Lalanne CM, Francoul M, Namer M: Thymidine labeling index and estrogen receptor level in 64 human breast cancers. Biomedicine 31:239, 1979

    PubMed  CAS  Google Scholar 

  38. Glascock RF, Hockstra WG: Selective accumulation of tritium-labelled hexoestrol by the reproductive organs of unmature female goats and sheep. Biochem J 72:673, 1959

    PubMed  CAS  Google Scholar 

  39. Hahnel R, Woodings T, Vivian AB: Prognostic value of estrogen receptors in primary breast cancer. Cancer 44:671, 1979

    PubMed  CAS  Google Scholar 

  40. Hankin JH, Rawlings PH, Rawlings V: Diet and breast cancer: a review. Am J Clin Nutr 31:2005, 1978

    Google Scholar 

  41. Hartveit F, Maartman-Moe H, Stou KF, Tangen M, Thor-sen T: Early recurrence in oestrogen receptor negative breast carcinomas. Acta Chir Scand 146:93, 1980

    PubMed  CAS  Google Scholar 

  42. Hartveit F, Thorenson S, Thorenson T, Tangen M: Histologic grade and efferent vascular invasion in human breast cancer. Br J Cancer 44:81, 1981

    PubMed  CAS  Google Scholar 

  43. Horsley JSIII, Horsley GW: Twenty years experience with prophylactic bilateral oophorectomy in the treatment of carcinoma of the breast. Ann Surg 155:935, 1962

    PubMed  Google Scholar 

  44. Horwitz KB, McGuire WL: Estrogen control of progesterone receptor in human breast cancer: correlation with nuclear processing of estrogen receptor. J Biol Chem 253:2223–2228, 1978

    PubMed  CAS  Google Scholar 

  45. Horwitz KB, McGuire WL: Studies on mechanisms of estrogen and antiestrogen action in human breast cancer. Recent Results in Cancer Research 71:45, 1980

    PubMed  CAS  Google Scholar 

  46. Horwitz KB, McGuire WL, Pearson O, Segaloff A: Predicting response to endocrine therapy in human breast cancer: a hypothesis. Science 189:726, 1975

    PubMed  CAS  Google Scholar 

  47. Huggins C, Bergenstal DM: Inhibition of human mammary and prostatic cancer by adrenalectomy. Cancer Res 12:134, 1951

    Google Scholar 

  48. Huggins C, Dao TL: Characteristics of adrenal dependent mammary cancer. Ann Surg 12:497, 1954

    Google Scholar 

  49. Jensen EV, DeSombre ER, Jungblut PW: Estrogen receptors in hormone responsive tissues and tumors. In: Endogenous Factors Influencing Host-Tumor Balance. Wissler RW, Dao TL, Wood S Jr, (eds.), pp. 15–30. Chicago, University of Chicago Press, 1967

    Google Scholar 

  50. Jensen EV, Jacobson HI: Fate of steroid estrogen in target tissues. In: Biologic Activities of Steroids in Relation to Cancer. Pincus G, Vollmer EP, (eds.), pp. 191, New York, Academic Press, 1960

    Google Scholar 

  51. Jungblut PW, Hatzel I, DeSombre ER, Jensen EV: Die oes-trogenbindenden Prinzipien der Erfolgsorgane. 18th. Coll Ges Phys Chemie (Mosbach), pp. 58–86, Berlin, Springer-Verlag. Über “Hormone, Rezeptoren”, 1967

    Google Scholar 

  52. Jungblut PW, Hughes A, Gaves J, Kallweit E, Maschler I, Parl F, Sierralta W, Szendro PI, Wagner RK: Mechanisms involved in the regulation of steroid receptor levels. J Steroid Biochem 11:273, 1979

    PubMed  CAS  Google Scholar 

  53. Kage AM, Jacobelli S, Bartoccioni E, Marchetti P: The “Estrogen-induced protein” in normal and neoplastic cells. Prog Cancer Res Ther 14:41, 1980

    Google Scholar 

  54. Keifer WS, Scott JC: A clinical appraisal of patients following long term contraception. Am J Obstet Gynec 122:446, 1975

    PubMed  CAS  Google Scholar 

  55. Kelsey JL: A review of the epidemiology of human breast cancer. Epidemiologic Reviews 1:74, 1979

    PubMed  CAS  Google Scholar 

  56. Kelsey JL: Epidemiologic studies of the role of exogenous estrogens in the etiology of breast cancer. In: Banbury Report 8: Hormones and Breast Cancer, Pike MC, Siiteri PK, Welsch CW, (eds.), pp. 215–225 Cold Spring Harbor Laboratory, 1981

    Google Scholar 

  57. Kennedy BJ: Hormonal therapies in breast cancer. Seminars in Oncology 1:119, 1974

    PubMed  CAS  Google Scholar 

  58. Kennedy BJ, Mielke PW, Fortuny IE: Therapeutic castration versus prophylactic castration in breast cancer. Surgery Gynec Obstet 118:524, 1964

    CAS  Google Scholar 

  59. Kiang DT, Kennedy BJ: ‘Intranuclear’ castration effect of high dose estrogens. Proc Am Ass Cancer Res/Am Soc Clin Oncol 17:194, 1976

    Google Scholar 

  60. Kinne DW, Ashikari R, Butler A, Menendez-Botet C, Rosen PR, Schwartz M: Estrogen receptor protein in breast cancer as a predictor of recurrence. Cancer 47:2364, 1981

    PubMed  CAS  Google Scholar 

  61. Knight WA III, Livingston RB, Gregory EJ, McGuire WL: Estrogen receptor is an independent prognostic factor for early recurrence in breast cancer. Cancer Res 37:4669, 1977

    PubMed  CAS  Google Scholar 

  62. Korenman SG: Oestrogen window hypothesis of the aetiology of breast cancer. Lancet 1:700, 1980

    PubMed  CAS  Google Scholar 

  63. Leake RE, Laing L McArdle C, Smith DC: Soluble and nuclear oestrogen receptor status in human breast cancer in relation to prognosis. Br J Cancer 43:67, 1981

    PubMed  CAS  Google Scholar 

  64. Lilienfield AM, Coombs J, Bross IDJ, Chamberlain A: Marital and reproductive experience in a community-wide epidemiologic study of breast cancer. Johns Hopkins Medical Journal 136:157, 1975

    Google Scholar 

  65. Lippman ME, Aitken SC: Estrogen and antiestrogen effects on thymidine utilization by MCF-7 human cancer cells in tissue culture. Progress in Cancer Research & Therapy 14:3, 1980

    CAS  Google Scholar 

  66. Lippman ME, Bolan G: Oestrogen-responsive human breast cancer in long term tissue culture. Nature 256:592, 1975

    PubMed  CAS  Google Scholar 

  67. Little M, Rosenfeld GC, Jungblut PW: Cytoplasmic estradiol receptors associated with the microsomal fraction of pig uterus. Hoppe-Seylers Z Physiol Chem 353:231, 1972

    PubMed  CAS  Google Scholar 

  68. Little M, Szendro PI, Teran C, Hughes A, Jungblut PW: Biosynthesis and transformation of microsomal and cytosol estradiol receptors. J Steroid Biochem 6:492, 1975

    Google Scholar 

  69. Logan WPD: Marriage and childbearing in relation to cancer of the breast and uterus. Lancet 2:1199, 1953

    Google Scholar 

  70. Lubin JH, Burns PE, Blot WJ, Lees AW, May C, Morris LE, Fraumeni JF Jr: Risk factors for breast cancer in women in northern Alberta, Canada, as related to age at diagnosis. J Natl Cancer Inst 68:211, 1982

    PubMed  CAS  Google Scholar 

  71. MacMahon B, Cole P, Brown J: Etiology of human breast cancer: a review. J Natl Cancer Inst 50:21, 1973

    PubMed  CAS  Google Scholar 

  72. MacMahon B, Cole P, Lin TM, Lower CR, Mina AP, Ravni-han B, Salber EJ, Valaoras G, Yvasa S (1970) Age at first birth and breast cancer risk. Bull WHO 43:209, 1970

    PubMed  CAS  Google Scholar 

  73. MacMahon B, Trichopoulos D, Brown J, Andersen AP, Aoki K, Cole P, deWaard F, Kauveniemi T, Morgan RW, Purde M, Ravnihar B, Stormby W, Westlund K, Wood N: Age at menarche, probability of ovulation and breast cancer. Int J Cancer 29:13, 1982

    PubMed  CAS  Google Scholar 

  74. Martin PM, Rolland PH, Jacquemier J, Rolland AM, Toye M: Multiple steroid receptors in human breast cancer. III. Relationship between steroid receptors and the state of differentiation and the activity of carcinomas throughout the pathologic features. Cancer Chemother Pharmacol 2:115, 1979

    PubMed  CAS  Google Scholar 

  75. Mason RC, Burns DA, Miller WR, Hawkins RA, Forrest APM: Tumor steroid hormone synthesis and estrogen receptor status in breast cancer patients. Breast Cancer Res Treat 1:263, 1981

    PubMed  CAS  Google Scholar 

  76. Maynard PV, Davies CJ, Blarney RW, Elston CW, Johnson J, Griffiths K: Relationship between oestrogen-receptor content and histologic grade in human primary breast tumors. Br J Cancer 38:745, 1978

    PubMed  CAS  Google Scholar 

  77. McCarty KS, Barton TK, Fetter BF, Woodard BH, Mossier JA, Reeves W, Daly J, Wilkinston W, McCarty K: Correlation of estrogen and progesterone receptors with histologic differentiation in mammary carcinoma. Cancer 46:2851, 1980

    PubMed  Google Scholar 

  78. McGuire WL, Horwitz KB: Progesterone receptors in breast cancer. In: Hormones Receptors and Breast Cancer, McGuire WL, (ed.), pp. 31–42, New York, Raven Press, 1978

    Google Scholar 

  79. McGuire WL, Carbone PP, Sears ME, Escher GC: Estrogen receptors in human breast cancer: an overview. In: Estrogen Receptors in Human Breast Cancer, McGuire WL, Vollmer EP, Carbone PP (eds.), pp. 1–7, Raven Press, New York, 1975

    Google Scholar 

  80. Meyer JR, Roa BR, Stevens SC, White WL: Low incidence of estrogen receptor in breast carcinomas with rapid rates of cellular replication. Cancer 40:2290, 1977

    PubMed  CAS  Google Scholar 

  81. Miller WR, Hawkins RA, Forrest APM: Steroid metabolism and oestrogen receptors in human breast carcinomas. Europ J Cancer Clin Oncol 17:913, 1981

    CAS  Google Scholar 

  82. Millis RR: Correlation of hormone receptors with pathologic features in human breast cancer. Cancer 46:2869, 1980

    PubMed  CAS  Google Scholar 

  83. Muss HB, Kute TR, Cooper MR, Marshall RC: The correlation of estrogen and progesterone receptors with DNA histograms in patients with advanced breast cancer. Proc Am Ass Cancer Res/Am Soc Clin Oncol 21:172, 1980

    Google Scholar 

  84. Nissen Meyer R: Prophylactic endocrine treatment in carcinomas of the breast. Clin Radiol 15:152, 1964

    Google Scholar 

  85. Norris HJ, Taylor B: Prognosis of mucinous (gelatinous) carcinoma of the breast. Cancer 18:879, 1965

    PubMed  CAS  Google Scholar 

  86. Osborne CK, McGuire WL: Endocrine therapy of metastatic breast cancer. In: Current Therapy in Endocrinology, Krieger DT and Bardin CW, (eds.), pp. 334–341 Toronto, BC Decker, Inc, 1983

    Google Scholar 

  87. Osborne CK, Yochmowitz MD, Knight WA III, McGuire WL: The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer 46:2884, 1980

    PubMed  CAS  Google Scholar 

  88. Paffenbarger RS Jr, Fasil E, Simmons ME, Kampert JB: Cancer risk as related to use of oral contraceptives during fertile years. Cancer 39:1887, 1977

    PubMed  Google Scholar 

  89. Panko WB, McLeod RM: Uncharged nuclear receptors for estrogen in breast. Cancer Res 38:1948, 1978

    PubMed  CAS  Google Scholar 

  90. Paterson AH, Zuck VP, SzaXrau O, Lees AW, Hansen J: Inference and significance of certain prognostic factors on survival in breast cancer. Europ J Clin Oncol 18(10): 937, 1982

    CAS  Google Scholar 

  91. Pinchon MF, Pallud C, Brunei M, Milgrom E: Relationship of presence of progesterone receptors to prognosis in early breast cancer. Cancer Res 40:3357, 1980

    Google Scholar 

  92. Poortman J, Thigssen JH, Schwartz F: Androgen production and conversion to estrogens in normal postmenopausal women and in selected breast cancer patients. J Clin Endocr Metah 37:101, 1973

    CAS  Google Scholar 

  93. Ramazzini B: Diseases of workers. Translated by WC Wright (1964), pp 167–202, New York, Hafner Publishing Co, 1713

    Google Scholar 

  94. Rich MA, Funnenski P, Brooks SC and the Breast Cancer Prognostic Study Surgery and Pathology Associates. Prognostic value of estrogen receptor determinations in patients with breast cancer. Cancer Res 38:4296, 1978

    PubMed  CAS  Google Scholar 

  95. Rochefort H, Borgna JL: Differences between oestrogen receptor activation by antioestrogen. Nature 292:257, 1981

    PubMed  CAS  Google Scholar 

  96. Rolland PH, Jacquemier J, Martin PU: Histologic differentiation in human breast cancer is related to steroid receptors and stromal elastosis. Cancer Chem Pharm 5:73, 1980

    CAS  Google Scholar 

  97. Royal College of General Practitioners: Oral Contraction and health. London, Pitman Medical, 1974

    Google Scholar 

  98. Rubens D: Adjuvant endocrine therapy of breast cancer. Breast Cancer Res Treat 2:407, 1982

    Google Scholar 

  99. Saez S, Chouret C, Majer M, Chix F: Estradiol and progesterone receptor as prognostic factors in human primary breast tumors. Proceedings of American Society of Clinical Oncology/American Association for Cancer Research 21:139, 1981

    Google Scholar 

  100. Samaan WA, Buydar AU, Aldinger KA, Schultz PN, Yong KP, Romsdahl MM, Martin R: Estrogen receptor: a prognostic factor in breast cancer. Cancer 47:554, 1981

    PubMed  CAS  Google Scholar 

  101. Santen RJ, Badder E, Lerman S, Harvey H, Lipton A, Boucher AE, Manni A, Rosen H, Wells SA: Pharmacologic suppression of estrogen with aminogluthamide as treatment of advanced breast carcinoma. Breast Cancer Res Treat 2:375, 1982

    Google Scholar 

  102. Schinzinger A: Über Carcinoma Mammae. Verh dt Ges Chir 18:28, 1889

    Google Scholar 

  103. Sherman BM, Korenman SG: Inadequate corpus luteum function: pathophysiological interpretation of human breast cancer epidemiology. Cancer 33:1306, 1974

    PubMed  CAS  Google Scholar 

  104. Sherman BM, Korenman G, Wallace RB: Corpus luteum dysfunction and the epidemiology of breast cancer: a reconsideration. Breast Cancer Res Treat 1:287, 1982

    Google Scholar 

  105. Shinghakowinata A, Potter HG, Buroker TR, Samals S, Brooks SC, Vaitkevicius V: Estrogen receptor and the natural course of breast cancer. Ann Surg 183:77, 1976

    Google Scholar 

  106. Silfversward C, Gustaf’sson J, Gustfa’sson SA, Humla S, Nordenskjold B, Wallgren A, Wrange O: Estrogen receptor concentrations in 269 cases of histologically classified human breast cancer. Cancer 45:2001, 1980

    Google Scholar 

  107. Stewart JF, King RJB, Sexton SA, Millis RR, Ruben RD, Hayward JL: Oestrogen receptors, sites of metastatic disease and survival in recurrent breast cancer. Europ J Cancer 17:449, 1981

    CAS  Google Scholar 

  108. Taylor GW: Ovarian sterilisation for breast cancer. Surg Gynecol Obstet 68:452, 1939

    Google Scholar 

  109. Taylor HB, Norris HJ: Well-differentiated carcinoma of the breast cancer 25:687, 1970

    CAS  Google Scholar 

  110. Thein-Hlany Thein-Maung: Risk factors of breast cancer in Burma. International J Cancer 21:432, 1978

    Google Scholar 

  111. Thomas DB: Noncontraceptive exogenous estrogens and risk of breast cancer: a review. Breast Cancer Res Treat 2:203, 1982

    PubMed  CAS  Google Scholar 

  112. Tulinius H, Day HE, Johannesson G, Bjarnason O, Gonzales M: Reproductive factors and risk for breast cancer in Iceland. International J Cancer 21:432, 1978

    Google Scholar 

  113. Varela RM, Doa TL: Estrogen synthesis and estradiol binding by human mammary tumors. Cancer Res 38:2429, 1978

    PubMed  CAS  Google Scholar 

  114. Vessey M, Doll R, Reto R: A long term followup study of women using different methods of contraception. J Biosoc Sci 8:373, 1976

    PubMed  CAS  Google Scholar 

  115. Vessey M, Doll R, Sutton PM: Oral contraception and breast neoplasia: a retrospective study. Br Med J 3:719, 1972

    PubMed  CAS  Google Scholar 

  116. Walt AJ, Shinghakowinata A, Brooks SC, Corley A: The surgical implications of the estrophile protein estimations in carcinoma of the breast. Surgery 80:506, 1976

    PubMed  CAS  Google Scholar 

  117. Wilking W, Carlstom K, Gustafsson SA, Sködefors H, Toll-bom O: Oestrogen receptors and metabolism of oestrone sulphate in human mammary carcinomas. Europ J Cancer 16:1339, 1980

    CAS  Google Scholar 

  118. Woods KL, Cove DH, Howe HA: Predictive classification of human breast carcinomas based on lactalbumin synthesis. Lancet 2: 14, 1977

    PubMed  CAS  Google Scholar 

  119. Young PCM, Ehrlich CE, Einhorn LH: Relationship between steroid receptors and response to endocrine therapy and cytotoxic chemotherapy in metastatic breast cancer. Cancer 46:2961, 1980

    PubMed  CAS  Google Scholar 

  120. Zava DT, Chamness GC, Horwitz KB, McGuire WL: Biologically active estrogen receptor in the absence of estrogen. Science 196:663, 1977

    PubMed  CAS  Google Scholar 

  121. Zava DT, McGuire WL: Human Breast Cancer: Androgen action mediated by estrogen receptor. Science 199:787, 1978

    PubMed  CAS  Google Scholar 

  122. Zenoff B, Fishman J, Bradlow HL, Hellman S: Hormone profiles in hormone dependent cancer. Cancer Res 35:3365, 1975

    Google Scholar 

Postscript References

  1. Bonadonna G, Valegussa P: The contribution of medicine to the primary treatment of Breast cancer. Cancer Res 48(9):2314, 1988

    PubMed  CAS  Google Scholar 

  2. Harmsen HJ Jr, Porsius AJ: Endocrine therapy of breast cancer. Eur J Cancer Clin Oncol 24(7): 1099, 1988

    PubMed  Google Scholar 

  3. Hart LL: Sequential hormonechemotherapy in advanced breast cancer (letter). Br Med J (Clin Res) 296(6617):293, 1988

    CAS  Google Scholar 

  4. Huff KK, Knabbe C, Lindsey R, et al.: Multihormonal regulation of insulin-like growth factor-I-related protein in MCF-7 human breast cancer cells. Mol Endocrinol 2(3):200, 1988

    PubMed  CAS  Google Scholar 

  5. Hug V, Thames H, Clark J: Chemotherapy and hormonal therapy in combination. J Clin Oncol 6(1): 173, 1988

    PubMed  CAS  Google Scholar 

  6. Murugesan K, Rao SV, Vij U, et al.: Effect of chemotherapy on gonadal function in women with breast cancer. Indian J Med Res 87:42, 1988

    PubMed  CAS  Google Scholar 

  7. Rose DP: Endocrine epidemiology of male breast cancer (review). Anticancer Res 8(4):845, 1988

    PubMed  CAS  Google Scholar 

  8. Secreto G, Recchione C, Zambetti M, et al.: Hormonal changes induced by the pure antiandrogen flutamide in postmenopausal women with advanced breast cancer. Eur J Cancer Clin Oncol 24(5):867, 1988

    PubMed  CAS  Google Scholar 

  9. Zumoff B: Hormonal profiles in women with breast cancer (review). Anticancer Res 8(4):627, 1988

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Charles F. LeMaistre
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. William L. McGuire
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. National Institutes of Child Health & Human Development, National Institutes of Health, Bethesda, Md., USA

    Arthur S. Levine

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Kluwer Academic Publishers, Dordrecht

About this chapter

Cite this chapter

LeMaistre, C.F., McGuire, W.L. (1989). Hormone Dependent Breast Cancer. In: Levine, A.S. (eds) Etiology of Cancer in Man. Cancer Growth and Progression, vol 6. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-2532-8_9

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-2532-8_9

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-7644-9

  • Online ISBN: 978-94-009-2532-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation